The liver-selective NO donor, V-PYRRO/NO, protects against liver steatosis and improves postprandial glucose tolerance in mice fed high fat diet

Article ID	Journal	Published Year	Pages	File Type
5823335	Biochemical Pharmacology	2015	43 Pages	PDF

Keywords

CPT 1 ALT MUFA SAT ABCA1 PPARα Cyt C pAkt HDL MTTP UFA SCD-1 GPAM Cytochrome c oxidase subunit 4 NAFLD CHOL ACC serine/threonine-protein kinase COX IV AMPK AUC pAMPK PacC AST Aspartate aminotransferase Alanine aminotransferase Akt Iodine value Liver steatosis Stearoyl-CoA desaturase 1 Polyunsaturated fatty acids fatty acid synthase PUFA saturated fatty acids Unsaturated fatty acids monounsaturated fatty acids non-alcoholic fatty liver disease Glucose tolerance Triacylglycerols TAG یا triacylglycerols Hepatoprotection diacylglycerols DAG Cer ceramides cytochrome c Fasn Lipid droplets lactate dehydrogenase LDH LDL Fatty acid metabolism area under the curve Nitric oxide microsomal triglyceride transfer protein high fat Carnitine palmitoyltransferase 1 HDL-cholesterol LDL-cholesterol total cholesterol peroxisome proliferator-activated receptor α

Related Topics

Health Sciences Pharmacology, Toxicology and Pharmaceutical Science Pharmacology

Preview

The liver-selective NO donor, V-PYRRO/NO, protects against liver steatosis and improves postprandial glucose tolerance in mice fed high fat diet

Authors

Edyta Maslak, Piotr Zabielski, Kamila Kochan, Kamil Kus, Agnieszka Jasztal, Barbara Sitek, Bartosz Proniewski, Tomasz Wojcik, Katarzyna Gula, Agnieszka Kij, Maria Walczak, MaÅgorzata Baranska, Adrian Chabowski, Ryan J. Holland, Joseph E. Saavedra,